Patents Assigned to Chemcom S.A.
  • Olfactory receptor involved in the perception of musk fragrance and the use thereof
    Patent number: 11867685
    Abstract: The invention relates to the identification of OR5A2 as an Olfactory Receptor that binds natural musk and synthetic musks. The invention encompasses the use of the interaction of OR5A2 polypeptides and nitromusk, polycyclic musk, macrocyclic musk and alicyclic musks as the basis of screening assays for agents that specifically modulate the activity of the OR of the invention.
    Type: Grant
    Filed: December 5, 2018
    Date of Patent: January 9, 2024
    Assignee: CHEMCOM S.A.
    Inventors: Sandra Huysseune, Alex Veithen, Yannick Quesnel
  • COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF
    Publication number: 20220378675
    Abstract: The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and X have the same meaning as that defined in the claims. The present invention also relates to consumer products comprising said agents. The present invention also relates to the use of said agents to suppress or attenuate undesirable odour, as well as to methods to suppress or attenuate undesirable odour employing said compounds.
    Type: Application
    Filed: June 1, 2022
    Publication date: December 1, 2022
    Applicants: CHEMCOM S.A., GIVAUDAN S.A.
    Inventors: Pierre Chatelain, Markus Gautschi, Thierry Granier, Yannick Quesnel, Charles Stanley Sell, Alex Veithen
  • Compounds reducing malodour perception and the use thereof
    Patent number: 11382848
    Abstract: The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and X have the same meaning as that defined in the claims. The present invention also relates to consumer products comprising said agents. The present invention also relates to the use of said agents to suppress or attenuate undesirable odour, as well as to methods to suppress or attenuate undesirable odour employing said compounds.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: July 12, 2022
    Assignees: CHEMCOM S.A., GIVAUDAN S.A.
    Inventors: Pierre Chatelain, Markus Gautschi, Thierry Granier, Yannick Quesnel, Charles Stanley Sell, Alex Veithen
  • COMPOUNDS REDUCING MALODOUR PERCEPTION AND THE USE THEREOF
    Publication number: 20190374451
    Abstract: The present invention relates to new malodour-counteracting agents of formula (I) or stereoisomers thereof, particularly useful in blocking the olfactory perception of androstenone, Formula (I), wherein R1, R2, R3, R4, R5, R6, R7 and X have the same meaning as that defined in the claims. The present invention also relates to consumer products comprising said agents. The present invention also relates to the use of said agents to suppress or attenuate undesirable odour, as well as to methods to suppress or attenuate undesirable odour employing said compounds.
    Type: Application
    Filed: January 30, 2018
    Publication date: December 12, 2019
    Applicants: CHEMCOM S.A., GIVAUDAN S.A.
    Inventors: Pierre Chatelain, Markus Gautschi, Thierry Granier, Yannick Quesnel, Charles Stanley Sell, Alex Veithen
  • Method for counteracting the perception of sweat malodour by decreasing the function of carboxylic acid-binding olfactory receptors
    Patent number: 8993526
    Abstract: The invention relates to the identification of carboxylic acids, present in human sweat, as natural ligands of a specific subgroup of seven olfactory receptor (OR) belonging to class 1 within the OR classification. The invention encompasses the use of the interaction of OR polypeptides and carboxylic acids as the basis of screening assays for agents that specifically modulate the activity of the seven ORs of the invention.
    Type: Grant
    Filed: June 12, 2013
    Date of Patent: March 31, 2015
    Assignee: ChemCom S.A.
    Inventors: Pierre Chatelain, Alex Veithen
  • Methods of identifying modulators of olfactory receptors involved in the perception of sweat carboxylic acids
    Patent number: 8637259
    Abstract: The invention relates to the identification of carboxylic acids, present in human sweat, as natural ligands of a specific subgroup of seven olfactory receptor (OR) belonging to class 1 within the OR classification. The invention encompasses the use of the interaction of OR polypeptides and carboxylic acids as the basis of screening assays for agents that specifically modulate the activity of the seven ORs of the invention.
    Type: Grant
    Filed: February 9, 2011
    Date of Patent: January 28, 2014
    Assignee: ChemCom S.A.
    Inventors: Pierre Chatelain, Alex Veithen
  • OLFACTORY RECEPTORS INVOLVED IN THE PERCEPTION OF SWEAT CARBOXYLIC ACIDS AND THE USE THEREOF
    Publication number: 20130336910
    Abstract: The invention relates to the identification of carboxylic acids, present in human sweat, as natural ligands of a specific subgroup of seven olfactory receptor (OR) belonging to class 1 within the OR classification. The invention encompasses the use of the interaction of OR polypeptides and carboxylic acids as the basis of screening assays for agents that specifically modulate the activity of the seven ORs of the invention.
    Type: Application
    Filed: June 12, 2013
    Publication date: December 19, 2013
    Applicant: CHEMCOM S.A.
    Inventors: Pierre Chatelain, Alex Veithen
  • Natural ligand of G protein coupled receptor RCC356 and uses thereof
    Patent number: 8008023
    Abstract: The invention relates to the identification of isovaleric acid as a natural ligand of the RCC356 G-protein coupled receptor (GPCR). The invention encompasses the use of the interaction of RCC356 polypeptides and isovaleric acid as the basis of screening assays for agents that modulate the activity of the RCC356 receptor. The invention also encompasses diagnostic and other assays performed based upon the RCC356/isovaleric acid interaction, as well as kits for performing diagnostic and screening assays.
    Type: Grant
    Filed: May 12, 2008
    Date of Patent: August 30, 2011
    Assignee: Chemcom S.A.
    Inventors: Frédéric Sallman, Alex Veithen, Magali Philippeau
  • Natural ligand of G protein coupled receptor RCC356 and uses thereof
    Publication number: 20090264526
    Abstract: The invention relates to the identification of isovaleric acid as a natural ligand of the RCC356 G-protein coupled receptor (GPCR). The invention encompasses the use of the interaction of RCC356 polypeptides and isovaleric acid as the basis of screening assays for agents that modulate the activity of the RCC356 receptor. The invention also encompasses diagnostic and other assays performed based upon the RCC356/isovaleric acid interaction, as well as kits for performing diagnostic and screening assays.
    Type: Application
    Filed: May 12, 2008
    Publication date: October 22, 2009
    Applicant: Chemcom S. A.
    Inventors: Frederic Sallman, Alex Veithen, Magali Philippeau
  • Novel in vitro methods for studying receptors recognizing volatile compounds
    Publication number: 20090136968
    Abstract: The present invention in particular relates to in vitro methods to identify and/or confirm the binding and/or function of a volatile compound onto a membrane-integrated receptor using volatile-compound-Binding Protein (BP) or compositions thereof. Additionally, the present invention relates to kits comprising receptor proteins recognizing volatile compounds or a candidate receptor for said compound; and; BP, a complex or composition thereof. Said kits may be used to identify and/or confirm the binding and/or function of volatile compounds onto a membrane-integrated receptor.
    Type: Application
    Filed: May 12, 2008
    Publication date: May 28, 2009
    Applicant: Chemcom S. A.
    Inventor: Frederic Sallman